Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO – Research Report) and ...

The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

Novo Nordisk has an analyst consensus of Hold, with a price target consensus of $84.83. According to TipRanks.com, Walton is ranked #6629 out of 9418 analysts. Sanofi has an analyst consensus of ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

Roche promised that its investments in the U.S. means it will export more medicines than it imports in the U.S.

Trump's looming tariff threats have prompted several announcements, even as the EU pleads for more investment in Europe.

Hundreds of lawsuits allege that insulin manufacturers and pharmacy benefit managers colluded to raise prices. The ...

Evotec’s cost-cutting drive has reached its pipeline. The company axed around 30% of its asset portfolio and offloaded ...